Skip to main content
Equibles

MERCER GLOBAL ADVISORS INC /ADV

Position in REPL — Replimune Group, Inc.

CIK 853758 DENVER, CO
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Aug 19, 2026
Position Value
$907,740
+$714,012 QoQ
Shares Held
82,000
+223.8% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 199 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 15% Shared 0% None 85%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MERCER GLOBAL ADVISORS INC /ADV holds $303,308,584 across 140 Biotechnology names. REPL ranks #26 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 APGE
Apogee Therapeutics, Inc.
 941,283 $124,936,492
2 CAPR
Capricor Therapeutics, Inc.
 802,732 $19,329,786
3 ORMP
Oramed Pharmaceuticals Inc.
 3,810,540 $18,328,697
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 30,705 $15,252,094
5 INCY
Incyte Corp
 116,207 $13,173,225
6 REGN
Regeneron Pharmaceuticals, Inc.
 20,126 $12,549,366
7 EXEL
Exelixis, Inc.
 176,339 $9,594,604
8 CORT
Corcept Therapeutics Inc
 102,823 $8,940,459

All Filings in REPL

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $907,740 82,000
2026-03-31 $193,728 25,324